Dear respectful colleagues,

WHO collects epidemiological and programmatic data for leprosy from all member states. These data are compiled by the Global Leprosy program (GLP) in SEARO and published in weekly epidemiological review (WER); the next publication is scheduled on 31 August 2018 and will compile the data for 2017.  

We kindly ask you to help us receiving the data for Georgia in electronic form. Detailed Standard Operational Procedure is attached and below you can find the username and password for Georgia.  

In addition, I would like to draw your attention to two important things:

• The country needs to report even if there is a zero cases in order to ensure data completeness and accuracy
• that last date for entering data is 30 June 2018 (Saturday).   

The steps mentioned below need to be followed  for login and entering data:

1.       Open the internet browser using Google chrome and enter the following URL

a.      http://dhis.searo.who.int/lep/dhis-web-commons/security/login.action

2.       Enter Username and password as mentioned against the name of the country or the WHO Country office.

3.       Select the desired language from the sign in page from the drop down on the lower right side of the sign in page.

4.       After signing in, you can change the password.  

5.       Data entry page will open in the selected language. (The default page is English)

6.       In the Data entry page country will be automatically selected

7.       Click on data set and the following forms will appear

a.       Leprosy core statistics

b.      Leprosy additional statistics

8.       Click on the period and select 2017

9.       The data set will appear for entering the data.

The ‘WHO GLP Phase 2 SOP – data entry – Leprosy statistics’ may please be referred for clarifications and also follow the guiding notes that pop-up while entering the data in each of the field. Presently data entry is possible using English, French, Spanish and Portuguese (Russian language to follow soon).

I cordially thank you for your support.

With best regards,